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In this study, the role of melanopsin-expressing retinal ganglion cells (mRGCs) in the glaucoma-induced depressive behavioral 
response pattern was investigated. The CFP-D2 transgenic glaucoma animal model from five age groups was used in this study. 
Immunohistochemical labeling, quantitative analysis of mRGC morphology, open field test (OFT), and statistical analysis were 
used. In comparison with C57 BL/6 mice, the age-matched CFP-D2 mice had significantly elevated intraocular pressure (IOP). 
We observed parallel morphological changes in the retina, including a reduction in the density of cyan fluorescent protein- 
(CFP) expressing cells (cells mm2 at 2 months of age, 1309±26; 14 months, 878±30, P<0.001), mRGCs (2 months, 48±3; 14 
months, 19±4, P<0.001), Brn3b-expressing RGCs (2 months, 1283±80; 14 months, 950±31, P<0.001), Brn-3b expressing 
mRGCs (5 months, 50.17%±5.5%; 14 months, 12.61%±3.8%, P<0.001), and reduction in the dendritic field size of mRGCs 
(mm2 at 2 months, 0.077±0.015; 14 months, 0.065±0.015, P<0.05). CFP-D2 mice had hyperactive locomotor activity patterns 
based on OFT findings of the total distance traveled, number of entries into the center, and time spent in the center of the test-
ing apparatus. The glaucoma induced hyperactive response pattern could be associated with dysfunctional mRGCs, most likely 
Brn-3b-positive mRGCs in CFP-D2 mice. 
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Glaucoma, a progressive retinal degenerative disease, is the 
second leading cause of blindness worldwide, with a dis-
proportionate bias towards women and Asians [1,2]. Pig-
mentary glaucoma is caused by disruption of the posterior 
iris by the lens zonule, leading to melanin pigment accumu-
lation within the anterior segment structures and the trabec-
ular meshwork, subsequently blocking aqueous outflow. 
Blockage of the aqueous outflow results in elevated intra-
ocular pressure (IOP), a consistent risk factor for glaucoma. 
High IOP then causes progressive peripheral to central 
death of retinal ganglion cells (RGCs) and their axons [3].  
Previous clinical studies have shown a high prevalence 
of depression, cognitive impairment, anxiety [4–14], and 
altered mood symptoms in patients with age-related eye 
diseases. Loss of RGCs results in loss of melanopsin-         
expressing RCGs (mRGCs) and axonal innervation of the 
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hypothalamic nuclei and basal limbic centers, including the 
suprachiasmatic nucleus (SCN), paraventricular nucleus 
(PVN), subparaventricular zone, ventrolateral preoptic area 
(VLPO), and medial amygdaloid nucleus (mMA) [15]. In-
deed, in addition to regulating circadian photoentrainment, 
mRGCs are also involved in the pupillary light reflex 
[16,17]. Recent findings also suggest that mRGCs are part 
of a neurocircuit that modulates memory and behavioral 
mood regulation [18,19], and therefore it is possible that 
loss of mRGCs can affect behavioral response patterns.  
Currently, many rodent glaucoma models are generated 
by a variety of techniques to elevate IOP or produce acute 
physical insults to RGC axons. In particular, RGC axotomy 
is induced by intraorbital optic nerve crush [20], optic nerve 
transection [21], elevated IOP-induced transient ischemia 
[22], or by selective ligature of the ophthalmic vessels [23]. 
Nevertheless, these animal models do not offer the clinical-
ly observed glaucomatous optic neuropathy (GON) of pro-
gressive degeneration of the RGC population. Recently 
there are glaucomatous animal models generated by specific 
genetic mutations, for instance, alteration of the serine pro-
tease (PRSS56) induced angle-closure glaucoma in mice 
[24]. The DBA/2J mouse, by contrast, is a well-established 
model of spontaneous pigmentary glaucoma. This mouse 
strain is characterized by age related elevation of IOP, pro-
gressive death of RGCs, and atrophic excavation of the op-
tic nerve. These pathological characteristics closely resem-
ble human glaucoma [25–27]. A Thy1-CFP D2 (CFP-D2) 
line was created by congenitally breeding the DBA/2J line 
(The Jackson Laboratory, Bar Harbor, ME, USA) with the 
Thy1-CFP line [28,29]. The Thy1-CFP mouse line trans-
genically labels the RGCs by a Thy1 promoter controlled 
cyan fluorescent protein (CFP). To better understand the 
relationship between GON-induced RGC degenerative 
morphology and GON-induced behavioral changes, our 
study characterized morphological alterations in conven-
tional RGCs (cRGCs) and mRGCs, and evaluated behavior 
at multiple ages in CFP-D2 mice compared to C57BL/6 
mice. Because the morphological properties of cRGCs in 
glaucoma retinas have been extensively studied, this current 
study concentrated on characterizing mRGCs. To quantita-
tively investigate morphological properties of mRGCs, we 
analyzed dendritic field area and dendritic branch pattern. 
Open field test (OFT) was used to assess behavioral charac-
teristics of rodents [30,31]. Thus, we measured OFT loco-
motor activity and anxiety levels of the C57BL/6 and 
CFP-D2 mice.  
1  Materials and methods 
1.1  Animals 
The transgenic Thy1-CFP-DBA/2J (CFP-D2) line was cre-
ated by crossing Thy1-CFP mice, which express CFP in 
ganglion cells, with DBA/2J mice, which develop progres-
sive pigmentary glaucoma. All mice were housed under 
specific pathogen-free conditions in the Animal Facility of 
Peking University Health Science Center, with controlled 
humidity and temperature (24±1°C), 12 h light/dark condi-
tions (light on at 6:00 a.m.), and with food and water ad 
libitum. A total of 40 female mice were used in these ex-
periments. Twenty-five were female CFP-D2 transgenic 
mice (from the University of California, Los Angeles, USA) 
at 2, 5, 8, 11, and 14 months of age (5 mice/age group), and 
15 were control female C57BL/6 mice (Peking University 
Health Science Center, China) at 2, 8, and 14 months of age 
(5 mice/age group). In addition, two age groups of older 
CFP-D2 mice (20 and 24 months of age) were used in the 
clinical slit-lamp examinations (two animals/group). All 
experiments were performed in accordance with the Asso-
ciation for Research in Vision and Ophthalmology State-
ment for the Use of Animals in Ophthalmic and Vision Re-
search. 
1.2  Clinical slit-lamp analysis 
The anterior segments of the CFP-D2 mice, in each age 
group, were examined using a slit-lamp microscope and 
photographed with a digital camera at 40× magnification. 
All photographs were taken under the same conditions and 
saved as BMP files. The images were processed with 
graphic software (Adobe Photoshop CS5, Adobe Systems, 
Inc., San Jose, CA, USA). 
1.3  IOP measurements 
IOP measurements were obtained from the CFP-D2 mice (2, 
5, 8, 11, and 14 months of age) and C57BL/6 mice (2, 8, 
and 14 months) using the TONO-PEN AVIA VET Tonom-
eter (Reichert, Inc., Depew, NY, USA). Mice were anesthe-
tized using intraperitoneal injections of ketamine (50 mg 
kg1) and xylazine (5 mg kg1). The tip of the Tonometer 
was gently applied toward the center of the cornea, and the 
measurements were displayed on the liquid crystal displays 
(LCDs). Once six readings were obtained, the LCD dis-
played the average IOP in millimeters of mercury (mm Hg), 
along with a statistical confidence indicator. To avoid diur-
nal variations, all IOP measurements were performed be-
tween 9:00 and 11:00 a.m. 
1.4  Tissue preparation and whole-mount retina im-
munohistochemistry  
Mice were euthanized with an overdose of ketamine and 
xylazine, the superior pole of each retina was burn-marked 
for orientation, and the eyes were removed and dissected. 
After the removal of the cornea, lens, and vitreous body, the 
retina was removed from the eyecup after 1 min in 4% par-
aformaldehyde (Electron Microscopy Sciences #15710, Ft.  
Washington, PA, USA), flattened between two slides with 
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spacers on both ends, and fixed for an additional 60 min. 
The retinas were then cryoprotected by immersion in 30% 
sucrose solution/0.1 mol L1 phosphate-buffered saline 
(PBS) at 4°C overnight. The next day, the retinas were 
placed in a 24-well tissue culture dish with gentle agitation 
on a shaker (unless otherwise stated, the following protocol 
was carried out on a shaker), and incubated in 1% sodium 
borohydride (in deionized water) for 1 h at room tempera-
ture. The free-floating retinas were rinsed six times with 0.1 
mol L1 PBS (pH 7.4) for 10 min per rinse, and then incu-
bated in a blocking solution containing 10% normal goat 
serum, 1% bovine serum albumin, and 0.5% Triton X-100 
in 0.1 mol L1 PBS for 2 h at room temperature. The block-
ing solution was removed and the primary antibody, diluted 
in blocking solution, was immediately added to the retinas, 
and the retinas were incubated for 3–5 d at 4°C. After rins-
ing six times to remove excess primary antibody, the retinas 
were incubated in secondary antibody for 4–6 h at room 
temperature. Following the final washing, the retinas were 
mounted onto glass slides with the ganglion cell layer up, 
air-dried, and a cover slip was added using the Fluoro-Gel II 
Mounting Medium (Electron Microscopy Sciences) con-
taining the fluorescent nuclear dye 4′,6-diamidino-2-      
phenylindole (DAPI). As a control for secondary antibody 
specificity, some retinas were processed in parallel for im-
munofluorescence staining, with the omission of primary 
antibody. These specimens showed no detectable signal. 
The preparations were evaluated using a fluorescence mi-
croscopy (BX51, Olympus, Okkonoki, Japan). 
1.5  Antibodies 
The optimal working dilution for each antibody was deter-
mined empirically. The primary antibodies and dilutions 
used in this study were as follows: goat anti-Brn-3b (1:50, 
SC-6026, Santa Cruz Biotech., Santa Cruz, CA, USA) [32], 
and polyclonal rabbit anti-melanopsin (1:2000, AB-N38, 
Advanced Targeting Systems Inc., San Diego, CA, USA) 
[33]. Immunolabeling with these primary antibodies was vis-
ualized using the following secondary antibodies: DyLight 
488 and DyLight 549, anti-rabbit IgG (1:1000, Vector Labs, 
Inc., Burlingame, CA, USA), DyLight 549 rabbit anti-goat 
IgG (H+L) (1:200, Kirkegaard & Perry Labs, Inc., 
Gaithersburg, MD, USA), and Alexa 594-conjugated don-
key anti-goat IgG (H+L) (1:1000, Molecular Probes, Grand 
Island, NY, USA). 
1.6  Cell count and morphologic analysis 
Entirely reconstructed retinal whole mount images taken 
with the fluorescent microscope (BX51, Olympus) were 
used to determine the average soma densities of CFP- and 
Brn-3b-expressing RGCs and mRGCs. Cell counts were 
determined from confocal reconstructions of the ganglion 
cell layer images taken from the retinal whole-mounts, and 
converted to cells mm2. For CFP- and Brn-3b-expressing 
RGCs density versus spatial quantification analysis, each 
retina was divided into superior, inferior, nasal, and temporal 
quadrants. Four predefined areas (200 m×200 m/micro-    
scope fields), with a separation of 600 m, along each 
quadrant, from the central to peripheral location of the reti-
na, were analyzed, corresponding to approximately 4% of 
the total retinal area. The total number of mRGCs in the 
entire retina was also counted and converted to cells mm2. 
CFP fluorescence was used as the primary ganglion cell 
marker. Retinas were also labeled with Brn-3b to confirm 
the presence of ganglion cells and cell nuclei. Images of the 
retina were captured using appropriate filters. The final 
publication quality images were exported in TIFF format at 
300 dpi using Adobe Photoshop CS5 (Adobe Systems, Inc.). 
For morphologic analysis, the number of primary dendrites 
of the mRGCs was quantified. For detailed investigation of 
dendritic patterns of the mRGCs, the dendritic field area and 
the branches of dendrites of each mRGC were examined 
using a modification of Sholl’s analysis method [34]. Spe-
cifically, concentric circles of increasing radius were drawn 
using the center of the soma as the circle center. The num-
ber of dendrites intersecting each circle was counted and 
plotted against the distance from the center of the soma 
(15–150 m). The morphology of the dendrites was also 
investigated in the cross-sectional plane by projecting the 
stacked images along the z-axis. A single-blind approach 
was used in all cell counting and measurements, to elimi-
nate any subjective bias. 
1.7  Behavior analysis using open field test (OFT) 
The OFT is an experimental method used to assay general 
locomotor activity and anxiety levels in rodents. In the pre-
sent study, each mouse (both C57BL/6 and CFP-D2 mice, 
five animals per age group) was placed in the center point 
of the open field apparatus (length 74 cm×width 74 cm×     
height 40 cm). The box was labeled by square crossing, and 
divided into 16 small grids (4×4). The center four grids re-
fer to the center part of the field. Each mouse was kept in 
the box for 8 min, and after a 2-min adaptation to the envi-
ronment, measurements were made, including the total dis-
tance traveled, the number of entries into the center, and the 
time spent in the center/total time spent for the following  
6 min. All animals were tested between 18:30 and 20:30. 
Total motor activity was quantified as the total distance 
traveled (mm). 
1.8  Statistical analysis 
All data were expressed as mean±standard deviation (SD). 
One-way analysis-of-variance (ANOVA; SPSS 13.0 for 
Windows, SPSS Inc., Armonk, NY, USA) followed by a 
post hoc Tukey multiple comparison test were used for each 
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analysis. Data analyzed included the IOP of CFP-D2 mice 
in each age group, cell counts, dendritic field area, and den-
dritic branching pattern obtained from Sholl’s analysis. 
P<0.05 was taken to be statistically significant. 
2  Results 
2.1  Evaluation of the anterior segment 
The anterior segments of 2- and 5-month-old CFP-D2 mice 
had normal morphological features. Iris atrophy and pig-
ment dispersion were not detected prior to 8 months of age 
(Figure 1A). Dispersed pigment and iris atrophy occurred in 
8-month-old CFP-D2 mice (Figure 1B) and severely dis-
persed pigment was observed around the pupillary border in 
11-month-old CFP-D2 mice (Figure 1C). Iris atrophy and 
severity of pigment dispersion increased with age in the 
CFP-D2 mice. Pigment dispersion was identified through-
out the anterior chambers, and keratic precipitates were also 
present on the cornea (across the surface of the iris) in 
14-month-old animals (Figure 1D). Large irregular accumu-
lations of pigmented debris were common in 20-month-old 
animals (Figure 1E). The iris was severely atrophied and the 
cornea continued to deteriorate, with the cornea showing 
calcification and nepheloid zones in 24-month-old animals 
(Figure 1F). With the development of the glaucoma pheno-
type, 20- and 24-month-old CFP-D2 mice appeared to have 
lost the normal features of the anterior segments. These de- 
 
 
Figure 1  Clinical appearance of anterior segments and iris morphology 
in CFP-D2 mice of different ages (slit-lamp analysis, 40×). A, Normal 
pupil in a 2-month-old CFP-D2 mouse. The pupil was surrounded by a 
regular iris with a clean edge. The pupil was dilated as the mouse was 
anesthetized. B, Dispersed pigment (green arrow) and iris atrophy (white 
arrow) in an 8-month-old mouse. C, Severely dispersed pigment around the 
pupillary border in an 11-month-old animal (green arrow). D, Pigment 
dispersion throughout the anterior chambers and keratic precipitates were 
also present on the cornea, across the surface of the iris, in a 14-month-old 
animal. E, A largely irregular accumulation of pigmented debris (green 
arrow) in a 20-month-old animal. F shows a severely atrophied iris, and the 
cornea was calcified and had nepheloid zones (opacity of cornea, with a 
translucent iris, and a fixed pupil which exhibits no response to light) (yel-
low arrow) in a 24-month-old CFP-D2 mouse. 
teriorating anterior features appeared exclusively in CFP-D2 
mice, in comparison with age-matched control animals. 
2.2  Elevation of IOP in CFP-D2 mice  
The age related progressive IOP elevation was determined 
quantitatively with direct IOP measurements. Fifty eyes 
from CFP-D2 mice and 30 from controls (C57BL/6 mice) 
were measured at ages ranging from 2 to 14 months. As 
shown in Figure 2, IOPs of control animals were stable with 
age. However, in CFP-D2 mice the average IOP level pro-
gressively increased with age from 2 to 11 months (Figure 2). 
In addition, the IOP level in CFP-D2 mice showed sharp ele-
vations even before the animals reached 11 months of age. In 
comparison to controls, the elevations of CFP-D2 mice were 
significantly different in all age groups (2 months of age, 
(15.2±0.84) mm Hg; 5 months, (17.8±0.45) mm Hg;      
8 months, (20.8±0.45) mm Hg, P<0.001). Although the 
elevated IOP appeared to plateau, the elevations were still 
significantly between 8 and 11 months of age (11 months, 
(22.2±0.84) mm Hg, P<0.01). However, the elevated IOP 
showed no significant difference between 11 and 14 months 
of age (14 months, (22.2±0.84) mm Hg, P>0.05).  
2.3  Changes in CFP expressing RGCs are an indicator 
of ganglion cell loss in CFP-D2 mice 
Whole mount retinas from CFP-D2 mice (Figure 3A) were 
processed for quantitative RGC counts. RGC measurements 
were made from retinas obtained from 2–14-month-old 
CFP-D2 mice. The average density (number of cells mm2) 
of CFP-expressing cells in the GCL decreased significantly 
with age (Figure 3B, 2 months of age, 1309±32; 5 months, 




Figure 2  Histogram comparing IOP as a function of age. The age related 
IOP elevation (mean±SD) was present in CFP-D2 mice, whereas IOP did 
not vary with age in C57BL/6 mice. Comparisons were made in CFP-D2 
mice (2 vs. 5 months of age, 5 vs. 8 months of age, 8 vs. 11 months of age, 
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878±34; 2 months of age vs. 5 months, P<0.001; 5 months 
vs. 8 months, P<0.01; 8 months vs. 11 months, P<0.01, and 
11 months vs. 14 months, P<0.01, n=4).   
2.4  Loss of Brn3b-expressing cells in the ganglion cell 
layer (GCL) in CFP-D2 mice 
In both C57BL/6 and CFP-D2 mouse strains, the densities 
of Brn-3b-positive cells were analyzed from whole-mount 
retinas obtained from 2–14-month-old mice. There was no 
significant change in the number of Brn3b-expressing cells 
in the GCL of C57BL/6 mice from 2–14 months of age 
(Figure 4E). However, there was variable loss of Brn3b-     
expressing RGCs in the GCL of the CFP-D2 retinas among 
the different age groups (Figure 4A–C). It is evident that 




Figure 3  CFP-expressing cell density in CFP-D2 mice. A, CFP-expressing cell distribution pattern in a whole-mount of CFP-D2 mouse retina. Four prede-
fined areas (200 m×200 m/microscope field area), with an interval of 600 m along each quadrant from the central retina were counted in each retina. B, 
Histogram comparing average density of CFP-expressing cells in the ganglion cell layer (GCL) (mean±SD) as a function of age. Comparisons were made 
between two age groups (2 vs. 5 months old, 5 vs. 8 months old, 8 vs. 1 months old, and 11 vs. 14 months old). Scale bar, 200 m. Conventions are the same 






Figure 4  Density distribution patterns of Brn-3b-expressing in RGCs in the GCL of CFP-D2 retina. A–C, Density distribution patterns of 
Brn-3b-expressing RGCs in retinas of three age groups: 2 months old (A), 8 months old (B), and 14 months old (C). The density distribution of 
Brn-3b-expressing cells (mean±SD) were counted and averaged from four retinas in each age group (n=4). D, Histogram comparing Brn-3-expressing RGCs 
in different age groups (2 vs. 5 months old, 5 vs. 8 months old, 8 vs. 11 months old, and 11 vs. 14 months old) in CFP-D2 mice. E, Brn-3b-expressing RGCs 
in CFP-D2 and control animals of different age groups as described above. Scale bar, 50 μm. **, P<0.01; ***, P<0.001. Conventions are as indicated in 
Figure 3. 
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the CFP-D2 mice (2 vs. 5 months of age, P<0.01, n=4; 11 
vs. 14 months of age, P<0.001, n=4). Nevertheless, the dif-
ferences are insignificant when comparing 5-month-old vs. 
8-month-old or 8-month-old vs. 11-month-old CFP-D2 ret-
inas (Figure 4D and E). 
2.5  Morphology of mRGCs in CFP-D2 mice 
The density of mRGCs was quantified in whole mount reti-
nas of CFP-D2 and control mice. The number of mRGCs in 
C57BL/6 whole-mount retinas did not vary with age 
(P>0.05, n=5) (Figure 5A–C, G and H). However, the den-
sity of mRGCs in CFP-D2 mouse retinas decreased signifi-
cantly with age, when comparing mRGC counts in 
2-month-old versus 11, 14-month-old retinas (P<0.001, 
n=5). However, there was no statistically significant differ-
ence between comparisons of similar age groups (2 months 
vs. 5 months, 5 months vs. 8 months, and 11 months vs. 14 
months) (P>0.05, n=5) (Figure 5D–H). 
To accurately map the changes in morphology of the 
mRGCs in CFP-D2 mice, we examined the number of pri-
mary dendritic branch points, the dendritic field area, and 
dendritic branching pattern of these cells. Although dendrit-
ic processes may overlap with dendrites of other mRGCs, the 
dendritic morphology of a well stained mRGC can be readily 
identified with high magnification microscope objectives. 
Using Sholl’s analysis, we quantitatively analyzed dendritic 
morphology and branching patterns of mRGCs. In compar-
ison with mRGCs from 2- and 8-month-old CFP-D2 mice, 
the average number of dendrites intersecting the circles in 
14-month-old mice was substantially reduced (P<0.05, 
n=10 cells per retina) (Figure 6C).  
Because the vast majority of M1s are Brn-3b-negative, 
this allows us to characterize expression differences be-
tween M1s compared to the other types of mRGCs (M2–5) in 
the CFP-D2 mice. Quantification of mRGCs co-expressing 
Brn-3b and melanopsin in CFP-D2 mice revealed a signifi-
cant loss of co-expression with age (Figure 7). However, 
there was still labeling of mRGCs with no Brn-3b staining 
(Figure 7B). In comparison, 8-month-old versus 14-month-old 
CFP-D2 mice expressed significantly decreased Brn-3b in 
mRGCs, however, this difference was not seen when com-
paring the other age groups (P<0.01, n=4) (Figure 7C).  
2.6  Abnormal behavioral patterns in CFP-D2 mice 
Locomotor activity was assessed using OFT on both 
CFP-D2 and C57BL/6 mice of different age groups. We 
analyzed three major parameters in the OFT, including the 
total distance traveled, the number of entries into the center,  
 
 
Figure 5  Density distribution patterns of mRGCs in retinas of CFP-D2 and control mice. A–C, Images captured from C57BL/6 mice of different age 
groups (2, 8 and 14 months old). D–F, Images captured from CFP-D2 mice of different age groups (2, 8, and 14 months old). The mRGCs were visualized 
by immunohistochemical staining with melanopsin antibody. G, mRGC densities in CFP-D2 and control retinas in different age groups (2 vs. 5 months old, 
5 vs. 8 months old, 8 vs. 11 months old, and 11 vs. 14 months old). H, Density of mRGCs (mean±SD) in GCLs of both C57BL/6 and CFP-D2 mice (n=5 
retinas/age group). Scale bar, 100 m. ***, P<0.001. Conventions are as shown in Figure 3.  
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Figure 6  Histograms comparing morphological properties of mRGCs as a function of age. The comparisons of mRGCs were made between C57BL/6 and 
CFP-D2 mice in four age-matched groups (2 vs. 5 months old, 5 vs. 8 months old, 8 vs. 11 months old, and 11 vs. 14 months old, n=10 cells/age group). A, 
Histogram comparing number of primary dendritic branch points as a function of age in C57BL/6 mice (mean±SD). B, Histogram comparing dendritic field 
area as a function of age in CFP-D2 mice. C, Comparisons of the number of dendritic branches intersecting each circle among three age groups (blue, 2 
months old; red, 8 months old; green, 14 months old). The abscissa designates the distance from the center of the soma (m). Vertical coordinates show the 




Figure 7  Reduction of Brn-3b-expressing mRGCs in CFP-D2 mice. Arrows in (A) and (B) show the doubly labeled RGCs in 5- and 14-month-old CFP-D2 
mice, respectively (melanopsin in green and Brn-3b in red). The histogram (C) shows results of quantitative comparisons. Quantification analysis of mRGCs 
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and time spent in the center versus total time in the box. 
CFP-D2 and C57BL/6 mice demonstrated distinctive loco-
motor activity patterns (Figures 8 and 9). CFP-D2 mice 
were highly active and had a sporadic running pattern (Fig-
ure 8B), while the C57BL/6 mice traveled less and main-
tained regular running tracks along the sides of the box 
(Figure 8A). Aging C57BL/6 mice showed a progressive 
reduction in total distance traveled, entries into the center, 
and time spent in the center (Figure 9) (P<0.05, n=5). 
However, CFP-D2 mice maintained highly active locomotor 
activity in all tested age groups (2, 8, and 14 months old) 
(Figure 9). 
3  Discussion 
The present study investigated the age-dependent pathologic 
changes of RGCs as glaucoma developed in CFP-D2 mice. 
The progressive elevation of IOP paralleled reduction in the 
average number of RGCs and mRGCs in the CFP-D2 mice. 
In comparison with C57BL/6 mice, CFP-D2 mice showed 
significantly increased locomotor activities. Thus, the pre-
sent study suggests that glaucoma-induced progressive loss 
of RGCs, especially mRGCs degeneration, could have a 
substantial impact on animal behavioral response patterns. 




Figure 8  Locomotion tracks of C57BL/6 and CFP-D2 mice as determined by OFT. A, Tracks of locomotor activity pattern of a C57BL/6 mouse. B, Lo-
comotor activity pattern of a CFP-D2 mouse, both at 14 months of age.  
 
 
Figure 9  Histograms comparing parameters of OFT in CFP-D2 and C57BL/6 mice as a function of age. Aging C57BL/6 mice showed a progressive reduc-
tion in total distance traveled (A), number of entries into the center (B), and time spent in the center (C). However, CFP-D2 mice maintained highly active 
locomotor activity in all tested age groups (2, 8, and 14 months old).  
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DBA/2J background. However, unlike the conventional 
DBA/2J line, the RGCs in CFP-D2 retinas can be directly 
visualized by the expression of CFP under the Thy-1 pro-
moter. Although CFP is not exclusively expressed in RGCs 
and is expressed in some cholinergic and displaced ama-
crine cells, misexpression is limited and minimal [35]. Us-
ing the CFP-D2 line, we investigated the general morphol-
ogy of CFP-expressing RGCs at different ages. The average 
number of CFP-expressing RGCs decreased with age and 
elevated IOP. Similarly, the average number of mRGCs 
declined with age in CFP-D2 mice. These findings suggest 
that CFP can be an effective RGC marker, as well as a 
marker for progressive degeneration of RGCs in CFP-D2 
mice.  
Clinical studies have associated a high prevalence of de-
pression with the development of glaucoma [4–14]. Simi-
larly, progressive degeneration of mRGCs has become the 
most striking clinical indicator of the progression of glau-
coma [36–38]. Morphological evidence shows that M1 pro-
jects to SCN and M2–5 innervate other non-visual nuclei 
[16,39,40]. The M1 cells are involved in regulation of cir-
cadian entrainment while M2–5 cells are responsible for 
other non-visual functions including pupillary light reflex 
[16,17]. Indeed, two early clinical studies showed that 
glaucoma patients suffered from afferent pupillary defects 
during the early stages of the disease [41], and underwent 
sleep disorders during later stages of the disease [6]. This 
implies that the non-image-forming visual pathway is dis-
turbed or impaired in these glaucoma patients. In addition, 
there is substantial evidence that mRGCs play an important 
role in the non-image-forming visual function including 
behavioral mood regulation [15–18]. In agreement with 
these observations, the present study suggests that preferen-
tial loss of M2–5 cells could affect the animal’s behavioral 
response patterns. We confirmed that mRGCs were severely 
affected by chronic IOP elevation in CFP-D2 mice (Figures 
2 and 5–7). However, other studies have demonstrated that 
mRGCs were not sensitive to acute IOP increase [42]. Jak-
obs et al. [43] reported that 2-month-old DBA/2J mice 
showed proportional loss of mRGCs that was not signifi-
cantly different from that of conventional RGCs. To date, 
however, few studies have investigated the link of RGC 
dysfunction, specifically the loss of mRGCs, to glaucoma 
induced behavioral response pattern changes or depressive 
behaviors. Therefore, our study provides novel and in-
formative details regarding progressive and developmental 
associations between mRGC morphology, glaucoma, and 
behavioral activity pattern changes. Several lines of evi-
dence demonstrate that loss of both cRGCs and mRGCs 
result in depression-like behavior, such as increased anxiety 
levels [44–47]. However, the specific neuromechanisms 
underlying conventional RGCs and mRGCs influence on 
behavioral moods remain to be investigated. 
The OFT is a well-established behavioral assessment for 
locomotor activity and level of anxiety in rodents [48]. It 
has also been used in studies evaluating the effects of anti-
depressant treatment in anxious animals [49]. In this study, 
we compared locomotor activity of C57BL/6 and CFP-D2 
mice at three ages (2, 8, and 14 months old). C57BL/6 mice 
showed reduction of locomotor activity with age, while 
CFP-D2 mice exhibited no statistically significant differ-
ences in total distance traveled, number of entries into the 
center, and time spent in the center/total time with age (2 vs. 
8 months old or 8 vs. 14 months old). It is plausible that 
highly active locomotor activities are not the result of loss 
of conventional RGCs or mRGCs, but are caused by other 
factors such as genetic mutations in this species [26,27, 
50,51]. The DBA/2J mouse is a popular model for anxiety- 
and locomotion-related behaviors [52,53], but this animal 
exhibits normal circadian rhythm [54]. In agreement with 
this finding, our results show that Brn-3b-negative mRGCs, 
which we suspect are M1-type mRGCs, had less injury than 
Brn-3b-positive mRGCs (M2–5) (Figure 7). These results 
suggest that abnormal behavioral response patterns could be 
due to injury of Brn-3b-positive mRGCs or are a compensa-
tion effect of the surviving Brn-3b-negative mRGCs. Indeed, 
depressive response patterns of this glaucoma mouse model 
can be reversed by antidepressant treatment [55]. Neverthe-
less, this study does not offer direct evidence to link the loss 
of mRGCs with the hyperactive behavior pattern observed 
in this glaucoma animal model. To address this question, 
one may consider selective elimination of mRGCs in the D2 
line. 
In conclusion, CFP-D2 mice have an age dependent in-
crease in IOP and parallel morphological deterioration of 
mRGCs, in particular Brn-3b-positive mRGCs. Concur-
rently, CFP-D2 mice have hyperactive locomotor activity 
and sporadic locomotor patterns. Together, the present 
findings suggest that glaucoma induced changes in locomo-
tor activity and behavioral patterns can be associated with 
dysfunctional mRGCs, most likely the Brn-3b-positive 
mRGCs, as observed in the CFP-D2 mouse line.  
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